Unjha Formulations Q2 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
22.99
0.14 (0.61%)
0.14 (0.61%)Volume96.00
Updated: Fri 13 Jun, 2025 | 10:30:20
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3.78 | 3.95 | -4.31% | 3.78 | N/A |
| Selling/ General/ Admin Expenses Total | 0.12 | 0.18 | -30.63% | 0.12 | N/A |
| Depreciation/ Amortization | 0.02 | 0.02 | 1.81% | 0.02 | N/A |
| Other Operating Expenses Total | 0.37 | 0.22 | 70.17% | 0.37 | N/A |
| Total Operating Expense | 3.91 | 3.25 | 20.29% | 3.91 | N/A |
| Operating Income | -0.13 | 0.70 | 0.00% | -0.13 | N/A |
| Net Income Before Taxes | -0.11 | 0.70 | 0.00% | -0.11 | N/A |
| Net Income | -0.11 | 0.70 | 0.00% | -0.11 | N/A |
| Diluted Normalized EPS | -0.25 | 1.56 | 0.00% | -0.25 | N/A |